A transgenic mouse that overexpresses PP5 in T cells in a doxycycline-inducible manner is currently being developed to test if PP5 causes a lupus-like phenotype and accelerated atherosclerosis in the apoE−/− model. This evidence concerns the gene APOE and atherosclerosis.